Lv7
5000 积分 2021-02-21 加入
Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer
3个月前
已完结
Overcoming tyrosine kinase inhibitor resistance in lung cancer brain metastasis with CTLA4 blockade
3个月前
已完结
Hepatic glycogenesis antagonizes lipogenesis by blocking S1P via UDPG
3个月前
已完结
Minimal residual disease as a target for liquid biopsy in patients with solid tumours
3个月前
已完结
Next-generation combination approaches for immune checkpoint therapy
4个月前
已完结
The future of immune checkpoint therapy
4个月前
已完结
Overcoming tyrosine kinase inhibitor resistance in lung cancer brain metastasis with CTLA4 blockade
4个月前
已完结
Challenges and opportunities in the PD1/PDL1 inhibitor clinical trial landscape
5个月前
已完结
The NKG2A immune checkpoint — a new direction in cancer immunotherapy
5个月前
已完结
Emerging targets in cancer immunotherapy
5个月前
已完结
皖公网安备34019202002308
